Lineage Cell Therapeutics (LCTX) Tops Q4 EPS by 2c, Revenues Beat

Go back to Lineage Cell Therapeutics (LCTX) Tops Q4 EPS by 2c, Revenues Beat
(NYSE: LCTX) Delayed: 1.06 -0.04 (3.64%)
Previous Close $1.10    52 Week High
Open $1.11    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.05    EPS
Volume 957,588